Skip to Content

Join the 'Diabetic Macular Edema' group to help and get support from people like you.

Diabetic Macular Edema News

Related terms: DME

Is Annual Eye Exam a Must for People With Type 1 Diabetes?

Posted 20 Apr 2017 by

WEDNESDAY, April 19, 2017 – People with type 1 diabetes face the risk of developing a disease that can cause blindness, so treatment guidelines have long called for annual eye exams. But new research suggests this one-size-fits-all advice is costly and ineffective, because people with a low risk may need less-frequent screenings while people at high risk may need to be seen more often. Diabetic ...

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in ...

Experts Undecided on Whether Seniors Should Get Routine Vision Checks

Posted 1 Mar 2016 by

TUESDAY, March 1, 2016 – There's just not enough good data to say whether or not seniors should be routinely screened for vision trouble by their primary care physicians, an influential panel of U.S. experts reports. The U.S. Preventive Services Task Force (USPSTF) believes current data isn't adequate to assess the potential benefits and harms of such screening in people 65 or older. The task ...

Study Compares Drugs for Common Diabetic Eye Disease

Posted 29 Feb 2016 by

MONDAY, Feb. 29, 2016 – People with diabetes are at risk for blurred vision or even a loss of vision from a condition called macular edema. Three drugs for the disease – Avastin, Eylea and Lucentis – vary widely in price, but new research suggests all work equally well for patients with mild vision loss. However, when diabetic macular edema leads to more severe vision loss, researchers found ...

Carrots Do Help Aging Eyes, Study Shows

Posted 8 Oct 2015 by

THURSDAY, Oct. 8, 2015 – Your parents may have told you, "Eat your carrots, they're good for your eyes," and a new study suggests they were on to something. Pigments called carotenoids – which give red or orange hues to carrots, sweet potatoes and orange peppers, or deep greens to produce like spinach, broccoli and kale – may help ward off the age-linked vision ailment known as macular ...

FDA Approves Eylea (aflibercept) for Diabetic Retinopathy in Patients with Diabetic Macular Edema

Posted 25 Mar 2015 by

March 25, 2015 – The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema. Diabetic retinopathy (DR) is the most common diabetic eye disease and is a leading cause of blindness in adults in the United States. According to the Centers for Disease Control and Prevention, diabetes ...

Study Compares Drugs for Diabetes-Linked Eye Disease

Posted 18 Feb 2015 by

WEDNESDAY, Feb. 18, 2015 – A vision-robbing condition called diabetic macular edema can strike people with diabetes. Now, a new study compared three leading drugs for the condition – Avastin, Eylea and Lucentis – and found that Eylea came out on top, at least for patients with "moderate" vision loss. The study, funded by the U.S. National Eye Institute (NEI), "will have a dramatic impact on ...

FDA Approves Revised Indication for Ozurdex for the Treatment of Diabetic Macular Edema

Posted 1 Oct 2014 by

IRVINE, Calif.-September 29, 2014 - Allergan, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Ozurdex (dexamethasone intravitreal implant) 0.7 mg, a sustained-release biodegradable steroid implant, for the treatment of diabetic macular edema (DME). Ozurdex was originally approved in June as a treatment for DME in adult patients who have an artificial lens ...

FDA Approves Iluvien for Diabetic Macular Edema

Posted 29 Sep 2014 by

WATERTOWN, Mass.--(BUSINESS WIRE)-- pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Iluvien for the treatment of diabetic macular edema (DME). It is indicated for patients who have been previously treated with a course of corticosteroids and did not have ...

Blacks May Face Higher Risk of Diabetes-Linked Vision Loss

Posted 21 Aug 2014 by

THURSDAY, Aug. 21, 2014 – Black Americans are at greater risk for diabetes-related vision loss than other racial groups battling the blood sugar disease, a new study says. Researchers analyzed data from the U.S. National Health and Nutrition Examination Survey, which evaluates about 5,000 people each year. They found that blacks had the highest rates of a condition known as diabetic macular ...

Eylea (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema

Posted 31 Jul 2014 by

TARRYTOWN, N.Y., July 29, 2014 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Eylea (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The recommended dosage of Eylea in patients with DME is 2 milligrams (mg) every two months (8 weeks) after five initial monthly injections. ...

Ask a Question

Further Information

Related Condition Support Groups

Macular Edema

Related Drug Support Groups

Eylea, Lucentis, fluocinolone, Ozurdex, Iluvien, ranibizumab, aflibercept